Vice President Alexion Corporate Affairs

Vice President Alexion Corporate Affairs

Are you ready to lead the charge in transforming the landscape of rare diseases? Pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease. Built on a legacy of turning pioneering science into transformative treatments, we listen to and partner with the rare disease ecosystem to help improve outcomes for more people impacted by rare diseases across the globe.

As the Vice President Alexion Corporate Affairs you will be responsible for developing and executing an integrated global corporate affairs strategy to advance Alexion's rare disease portfolio and reputation. As an executive leader you will sit on both the Alexion Leadership Team and AstraZeneca's Global Corporate Affairs Leadership Team (CALT), with direct oversight of country and regional Corporate Affairs teams (markets) reporting into the role. A key element of your role will be to manage, align, and mentor these teams to ensure local and global objectives are consistently and effectively met, in line with business priorities, while maintaining robust budget discipline and leveraging advanced AI and digital tools.

Operating within a rapidly evolving, matrixed organization, you will require exceptional agility and comfort with ambiguity, adapting to complex and changing reporting structures and collaborating across enterprise geographies. The position requires robust budget discipline, advanced use of AI and digital tools, and the ability to inspire creativity, confidence and resilience across local, regional, and global teams.

Key Responsibilities

Strategic Leadership

• Define, develop, and deliver a robust global corporate affairs strategy for rare disease, in alignment with Alexion's business priorities.
• Serve as a member of both the Alexion Leadership Team and CALT, ensuring corporate affairs objectives drive key business outcomes.
• Shape and champion key Global Corporate Affairs initiatives / programmes that are critical to the delivery of our strategy.
• Act as a business partner to Alexion CEO in shaping overall business strategy as well as senior executive engagement plan / visibility.

Market and Regional Leadership

Policy Shaping & Access Advocacy

Product and Scientific Communications

Corporate Communications, AI & Digital Leadership

Metrics, Governance & Compliance

External Stakeholder Engagement

Team Leadership, Talent Development & Change Management

Budget Management and Resource Stewardship

Key Requirements

Delivering life changing medicines. Pioneering in science is in our DNA. We innovate on behalf of patients and families with unmet need and follow the science to deliver life-changing medicines. We do this because the challenge of rare disease is enormous, and the patient need is high. Of the 10,000 known rare diseases, 90% do not have an approved treatment. We have more than 30 years of rare disease leadership and 20-plus years of real-world evidence. Today, this has resulted in 7 approved medicines across 8 rare diseases. With one of the most robust early to late-stage research pipelines in rare disease, we aim to deliver five (5)